Zbh investor relations9/16/2023 ![]() ![]() Mick holds a Bachelor of Engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology (MIT), and a Master of Business Administration from the MIT Sloan School of Management. Mick also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, and Father Joe’s Villages’ project for the homeless in San Diego, California. He is a member of two committees at Zimmer Biomet: the compensation and management development committee, as well as the quality, regulatory, and technology committee, of which he is chair. In the last reported quarter, the company’s earnings of 1.82 exceeded the Zacks. ZBH is scheduled to report third-quarter 2022 results on Nov 2, before market open. Mick serves on the board of directors of the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a global provider of implantable musculoskeletal medical devices. 1 day ago &0183 &32 Zimmer Biomet Holdings, Inc. Little, Sanofi Genzyme, Dow Chemical, and BHP. ![]() ![]() He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development.īefore joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at companies including Arthur D. Michael “Mick” Farrell was appointed ResMed’s CEO and has served as a director since March 2013. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |